HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of molluscum contagiosum with intralesional immunotherapy by measles, mumps, and rubella vaccine: a report of two cases.

Abstract
Molluscum contagiosum (MC) is a common viral infection of the skin and mucous membrane that often affects young children. Generally, physical removal by surgical curettage is commonly used for the treatment of MC, but the pain during the treatment is a major problem. Thus immunotherapy using various antigens has been introduced recently. Here we present two cases of MC that improved with measles, mumps, and rubella (MMR) vaccine intralesional injection. On the ground of our knowledge, they were the first cases of successful MMR intralesional injection in this disease entity.
AuthorsChan Ho Na, Dong Jin Kim, Min Sung Kim, Jong Kyu Kim, Bong Seok Shin
JournalDermatologic therapy (Dermatol Ther) 2014 Nov-Dec Vol. 27 Issue 6 Pg. 373-6 ISSN: 1529-8019 [Electronic] United States
PMID25053017 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • Measles-Mumps-Rubella Vaccine
Topics
  • Child, Preschool
  • Humans
  • Infant
  • Injections, Intralesional
  • Male
  • Measles-Mumps-Rubella Vaccine (administration & dosage)
  • Molluscum Contagiosum (diagnosis, drug therapy, immunology, virology)
  • Remission Induction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: